As the GFF wraps up its sixth year of operations, enters its next strategic period, and undertakes an important replenishment campaign to raise an additional $2.5 billion in trust fund resources, we are excited to share new work on the role of the GFF in improving the impact of health spending for RMNCAH-N.
CGD Policy Blogs
We Have a New Tool to Help End the Pandemic—Now the Biden Administration Needs to Step Up and Seize the Opportunity
At current death rates, getting Paxlovid out in the world could save 1,200 American lives every day—and another 5,000 across the world. We don’t have a moment to lose.
Antibiotic resistance (AMR) is not a new problem. However, the global community has been slow to implement recommended policy measures and achieve systemic change. CGD will launch a working group on antimicrobial resistance—seeking to improve antibiotic access and R&D in low- and middle-income countries, and reduce unnecessary use.
Make Me a Match: We Want Your Ideas to Kick-Start Promising Global Health Innovations with Demand-Side Funding
Scientific and technological innovation has the potential to save lives, reduce global poverty, and help address the most pressing global challenges—but investments in R&D are mostly directed at lucrative, high-income markets versus the health problems that affect the global poor.
The early days of the US International Development Finance Corporation (DFC) have been defined by a mixed record, and its health-focused investments are no exception. In the face of competing foreign (and even domestic) policy priorities under the Trump Administration and pandemic-related shifts in the broader development landscape, the agency has struggled to build a solid pipeline of projects in lower-income markets and systematically articulate a strong development rationale for its financing.
Dear President Biden and Congress: Time for US to Lead Response to the Growing COVID-19 Global Vaccine Crisis
Today we joined colleagues from CSIS, Duke University, and the COVID Collective in an open letter to the Biden Administration and US Congress with a clear message: to hasten the end of the COVID-19 global pandemic, American leadership is required to ensure universal global access to high-quality and safe vaccines, support rapid vaccine distribution and administration, and build a sustainable global network of vaccine manufacturing capacity. Vaccines offer an exit route out of the pandemic – but only if they reach a critical mass of people in need across continents, socioeconomic strata, and marginalized populations.
Enough. We cannot continue business as usual. Until this crisis is over—and over everywhere—exiting the COVID-19 mass casualty event must be the singular focus of the international community.
Biden Wants to Eliminate Lead Poisoning in American Children. We Propose an Even More Ambitious Goal: Global Eradication.
We applaud the Biden Administration's effort to address lead poisoning in the US. But we suggest Biden adopt an even more ambitious goal: not just national elimination, but global eradication of lead poisoning, especially in children. A global eradication campaign—modelled loosely on prior and ongoing global efforts to eradicate smallpox, polio, and guinea worm, mixed with inspiration from the WHO’s Framework Convention on Tobacco Control—would offer a tremendous contribution to global welfare, economic growth, and even world peace. An American-led effort to eliminate lead poisoning globally could be an international moonshot elevating the Biden administration’s international statue and legacy.
Bridging the Gap between Health Financing and Family Planning: How to Effectively Advocate for Contraception in UHC
Drawing from a workshop in February 2020, the authors offer an evidence review and proposed approach to inform policymakers as they evaluate contraception for inclusion in health benefits packages.